Contact this trialFirst, we need to learn more about you.
Immunotherapy
Lenalidomide + Dexamethasone +/- Daratumumab for Multiple Myeloma
Recruiting2 awardsPhase 3
Adrian, Michigan
This trial is testing Lenalidomide + Dexamethasone with or without Daratumumab to see if it can better treat patients with high-risk smoldering myeloma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service